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Abstract  
 
Background 
Dietary non-digestible carbohydrates stimulate the gut microflora and are therefore presumed to 
improve host resistance to intestinal infections. However, several strictly controlled rat infection studies 
showed that non-digestible fructo-oligosaccharides (FOS) increase, rather than decrease, 
translocation of Salmonella towards extra-intestinal sites. In addition, it was shown that FOS increases 
intestinal permeability already before infection. The mechanism responsible for this adverse effect of 
FOS is unclear. Possible explanations are altered mucosal integrity due to changes in tight junctions 
or changes in expression of defense molecules such as antimicrobials and mucins. To examine the 
mechanisms underlying weakening of the intestinal barrier by FOS, a controlled dietary intervention 
study was performed. Two groups of 12 rats were adapted to a diet with or without FOS. mRNA was 
collected from colonic mucosa and changes in gene expression were assessed for each individual rat 
using Agilent rat whole genome microarrays.  
Results 
Among the 997 FOS induced genes we observed less mucosal integrity related genes than expected 
with the clear permeability changes. FOS did not induce changes in tight junction genes and only 8 
genes related to mucosal defense were induced by FOS. These small effects are unlikely the cause 
for the clear increase in intestinal permeability that is observed. FOS significantly increased 
expression of 177 mitochondria-related genes. More specifically, induced expression of genes 
involved in all five OXPHOS complexes and the TCA cycle was observed. These results indicate that 
dietary FOS influences intestinal mucosal energy metabolism. Furthermore, increased expression of 
113 genes related to protein turnover, including proteasome genes, ribosomal genes and protein 
maturation related genes, was seen. FOS upregulated expression of the peptide hormone 
proglucagon gene, in agreement with previous studies, as well as three other peptide hormone genes; 
peptide YY, pancreatic polypeptide and cholecystokinin. 
Conclusion 
We conclude that altered energy metabolism may underly colonic barrier function disruption due to 
FOS feeding in rats. 
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Background 
 
Non-digestible carbohydrates like fructo-oligosaccharides (FOS) stimulate the gut microflora and are 
therefore presumed to improve host resistance to intestinal infections. For this reason non-digestible 
carbohydrates are added to a growing list of products, including baby-formula, bread, dairy products. 
Many studies, including our own, showed that non-digestible carbohydrates indeed affect intestinal 
microflora composition[1-3]. However, there is little evidence that these non-digestible carbohydrates 
strengthen intestinal resistance to infection and gut barrier function.  
For this reason, several strictly controlled rat infection studies were previously performed at our lab. 
These studies consistently showed that the non-digestible carbohydrates inulin, lactulose and FOS 
increase translocation of Salmonella to extra-intestinal organs[3-5]. A dose-dependent increase in 
Salmonella translocation was observed in FOS-fed rats[3]. Stimulation of Salmonella translocation by 
dietary FOS was reflected in transcriptional changes in colon. Genes involved in antimicrobial defense, 
immune response and inflammation were induced by Salmonella infection of rats on a control diet and 
further upregulated in Salmonella infected rats on a FOS diet [6]. Moreover, intestinal barrier 
parameters were already affected by FOS before infection. In particular intestinal permeability was 
increased by FOS before Salmonella challenge.  Also, luminal cytotoxicity and faecal mucin excretion 
were increased in FOS-fed rats and may indicate mucosal irritation[5].  
 
The intestinal barrier is mainly formed by the mucosal epithelial lining. Disturbed barrier function can 
be monitored by measurement of epithelial permeability using inert permeability markers such as 
different kind of sugars or CrEDTA[7, 8]. It has been shown that increased transport of large molecules 
or antigens due to increased permeability may initiate inflammation[9]. Several mechanisms have 
been implicated in the mucosal barrier. Tight junctions tightly connect the epithelial cells and regulate 
paracellular transport of fluids, electrolytes and small compounds[10]. Modification or cellular 
translocation of the tight junction molecules ZO1 and several claudins have indeed been observed in 
inflammatory bowel disease (IBD) and chronic non-steroidal anti-inflammatory drugs (NSAIDs) use, 
both characterized by increased intestinal permeability[11, 12].  
In addition to changes in epithelial tight junctions, balance between apoptosis and proliferation, or 
regeneration, is also a major determinant of an intact mucosal epithelial lining[13]. Increased apoptosis 
can induce epithelial leakage as shown in colonic epithelial cell lines and in intestinal biopsy 
specimens of IBD patients[14]. 
Apart from tight junctions and apoptosis, secretory products of intestinal epithelial cells are known to 
play a role in mucosal barrier. The different intestinal epithelial cells; enterocytes, goblet cells, Paneth 
cells and enteroendocrine cells, are equipped with defense mechanisms. For instance Paneth cells in 
the crypt base produce antimicrobials, such as defensins, lysozyme and Pla2g2a[15], to regulate and 
restrict the bacterial load in the gut lumen. Goblet cells produce mucins to form a mucus layer, this 
layer functions as a physical barrier that protects the epithelial cells from harmful compounds[16]. 
Furthermore, the immune system plays an important role in mucosal integrity[17]. Whether other 
processes are involved and the relative importance of these mechanisms for intestinal barrier integrity 
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is not known. Also it is not known if any of the above mentioned mechanisms or others are responsible 
for the effect of FOS on gut permeability.  
Therefore, we analyzed colonic gene expression changes in individual rats fed a 6% FOS diet for 2 
weeks. Analyzing FOS induced gene expression using whole genome microarrays allowed us to not 
only focus on the above mentioned mechanisms, but to obtain an unbiased view on processes 
affected by dietary FOS. This facilitates identification of genes and processes currently unknown to be 
related to barrier function. The colon had our main interest as FOS and other non-digestible 
carbohydrates are exclusively fermented in the distal gut in humans[18] and rats[3]. We aimed to 
identify the in vivo biological mechanisms involved in FOS-induced weakening of the barrier in rats. 
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Results 
 
Food intake, body weight gain, and intestinal permeability 
Rats on the control diet and FOS diet showed no significant difference in body weight gain. Both 
dietary groups consumed the provided 14 grams of diet per day as intended and thus had a similar 
dietary CrEDTA intake. Intestinal permeability was examined by measurement of CrEDTA excretion in 
urine and showed that FOS fed rats had increased urinary excretion of this inert permeability marker 
as compared to the control group (figure 1).  
 
Gene expression profile  
28180 probes on the array had an expression value of 1.5 times above background. Of these 123 
were induced and 56 were reduced more than 1.5 fold in FOS fed rats compared with rats fed the 
control diet. Only 19 probes were induced more than 2-fold. While gene expression changes induced 
by FOS supplementation were small, there were many significantly changed probes in the dataset: 
803 had a p-value < 0.001, and 231 probes had a FDR derived q-value<0.01. This indicated that the 
gene expression response of colon mucosa to FOS was small in magnitude, but highly significant. As 
each probe signal is tested independently in t-test and multiple testing increases the risk for finding 
false positives, we also applied Random Forest[19, 20]. RF ranks genes based on an importance 
value taking main treatment effect as well as gene-gene interaction into account[20]. Using RF, we 
identified 935 probes with an importance value above threshold. 629 were selected by both the t-test 
and RF. To prevent loss of information, we used all genes selected by t-test and RF. This resulted in a 
list of 1109 probes. 112 corresponding genes were listed more than once. Therefore, duplicates with 
the highest p-values were removed, resulting in 997 unique genes regulated by FOS 
Gene selection by t-test or RF alone substantially overlapped and did result in a highly comparable 
outcome in pathway analysis, showing that the main effects extracted by both methods were similar. 
However, the individual gene selection differed slightly between both methods. We choose to include 
all genes selected by either method. 
 
Effect of FOS on the expression of barrier associated genes 
As FOS affects the mucosal barrier, we specifically analyzed genes that are known or assumed to play 
a role in barrier function. These include tight junction genes like Zo-1, occludin and claudin, cell 
turnover/apoptosis genes such as caspases, Bak, Bcl-2, and mucosal defense genes such as 
defensins, lipocalin, toll like receptors and IgA (additional file 1). Tight junction related genes were not 
affected by FOS. Several apoptosis (for example Bax, DNase1, Pdcd 6 & 8) and mucosal defense 
genes (for example phospholipase A2 and trefoil factor 1 & 3) were increased by FOS (additional file 
1). However, no FOS effect was found on other mucosal defense genes like IgA, Mucin 2 & 3, 
defensins, lipocalin, calprotectin, and most toll-like receptors. In addition, some markers of apoptosis 
were slightly affected (Bak, Caspase 7), while most (including Apaf, Caspase 9, caspase 3, caspase 2, 
Bcl2 and Bad) were not affected by FOS.  
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Genes most prominently affected by FOS 
We examined the top 10 of genes most affected by the FOS diet (table 1). We choose the genes most 
prioritized by RF. These genes were characterized by extremely low p-values and relatively high fold 
changes. The genes were related to nutrient homeostasis (proglucagon), energy metabolism (NADH 
dehydrogenases (Ndufb6, Ndufa4 and Ndufb5) and ATP synthase (Atp5f1)), protein turnover 
(Proteasome subunit alpha type 3-like (Psma3l)), oxidative stress response (Metallothionein-2 (Mt-2)) 
and retinol metabolism (cellular retinol-binding protein (Rbp7)). This top-10 list indicates that FOS 
especially affects cellular energy metabolism in rat colonic mucosa, this was supported by the pathway 
analysis results, as described below. 
 
Pathway analysis 
Pathway analysis identified processes most affected by dietary FOS in colonic mucosa. 366 Genes of 
the 997 selected genes could be classified based on GO term or based on GeneGo annotation in the 
Metacore database[21]. The most significant processes were an entire range of mitochondria related 
processes such as mitochondrial electron transport, oxidative phosphorylation, translation in 
mitochondria and proteins targeted to mitochondria (additional file 2). Another highly classified process 
was proteolysis (additional file 2). To prevent bias in biological interpretation due to gene selection (by 
t-test and RF), we also applied Gene Set Enrichment Analysis (GSEA) which includes all genes in the 
dataset (28180 genes). We focused on curated gene-sets originating from GenMapp, Biocarta, 
SigmaAldrich and Broad institute. Comparable biological processes were found by GSEA as observed 
in Metacore: again oxidative phosphorylation was most significant, followed by proteasomal 
degradation (additional file 3). Thus the threshold based Metacore analysis and the threshold free 
enrichment analysis, GSEA, gave similar results for the most significantly changed processes by FOS. 
The results obtained by pathway programs consist of many overlapping pathways. We combined 
pathways with overlapping genes such as mitochondrial electron transport (Metacore), electron 
transport (Metacore) and electron transport chain (GSEA) and categorized the processes. 
Analysis based on pathway programs is restricted to the well annotated genes[22]. As only 36% of the 
Agilent whole genome array is recognized by Metacore and only 35% by GSEA, we manually 
extended the significantly altered pathways with the non-recognized genes using literature and 
databases mining (using Biocarta, Source, Genecards). This strengthened the pathway outcome, as 
we were able to identify many additional genes affected by FOS that could be added to the processes 
already identified by the pathway programs. This was the case for transcription identified by Metacore 
as nucleosome assembly, cell turnover identified by GSEA as programmed cell death, cytoskeleton 
and vesicle related processes (muscle filament sliding and cytoskeleton-dependent intracellular 
transport in Metacore) and oxidative stress (free radical induced apoptosis in GSEA) (figure 2). In 
addition, we identified FOS affected genes that were not grouped into a pathway by both programs but 
obviously belong to the same biological process, this was the case for mucosal barrier, transport, and 
peptide hormones (figure 2).   
Detailed analysis of the mitochondrial processes showed an increased expression of genes 
associated with al five complexes of the OXPHOS complex, TCA-cycle and mitochondrial ribosomes 
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and mitochondrial protein transport (table 2). In addition to protein degradation, which was found in the 
pathway programs, protein translation and maturation were also affected by FOS. From these 113 
genes more than 90% showed increased expression upon FOS indicating increased protein turnover 
(table 2). Detailed gene expression data for all processes mentioned in table 2 is presented in 
additional file 4. 
 
Confirmation of array results by Q-PCR. 
Confirmation of FOS induced processes was performed by Q-PCR. Genes from several FOS affected 
processes were analyzed by individual Q-PCR. We selected nine genes from mitochondria related 
processes: NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9 (Nduf9b), succinate 
dehydrogenase complex subunit B (Sdhb), ubiquinol-cytochrome c reductase binding protein 
(UbiqcytC), cytochrome c oxidase subunit VIIb (Cox7b), ATP synthase H+ transporting mitochondrial 
F0 complex subunit G (ATP5g), aldo-keto reductase family 1 member B8 (Akr1b8), malic enzyme 1 
(Me1), mitochondrial ribosomal protein S16 (RiboS16) , translocase of inner mitochondrial membrane 
8 homolog b (Timm8b). In addition, one gene from protein degradation proteasome subunit alpha type 
3-like (Psma3l), two genes related to mucosal barrier phospholipase A2, group IIA (platelets synovial 
fluid)  (Pla2g2a) and trefoil factor 3 (Tff3) and one gene from the peptide hormones, proglucagon 
(Gcg) were analyzed. We additionally selected retinol binding protein 7 (Rbp7) as this gene was 
highest induced by FOS (4-fold). Q-PCR fully confirmed the microarray data (table 3). The p-value in 
the Q-PCR analysis reached significance (p<0.05) for 11 out of 13 genes. Two genes had a p-
value>0.05 (ATP5g and Timm8b).   
 
Confirmation of gene expression results on protein level 
To substantiate the FOS induced transcriptional modulation of mitochondrial genes at the protein level, 
we analyzed pooled mucosal scrapings of all rats (n=12 per group). The small increase in mRNA 
levels of complex IV subunits (~1.4 fold), was confirmed by a similar increase (1.5, 1.7 and 2.7 fold in 
independent pools, relative to actin) in protein levels of complex IV subunit COX II in the FOS group 
compared with the control group in pooled (n=12) mucosal scrapings (figure 3).  
The relatively high and significant induction of proglucagon gene by FOS was also examined at the 
protein level. Mucosal scrapings of randomly sampled control and FOS-fed rats (n=7 per group) were 
analyzed for GLP-1 protein levels by western blot and normalized to actin. FOS significantly increased 
GLP-1 protein levels in colonic mucosal tissue (Figure 4), substantiating the gene expression findings. 
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Discussion 
 
The CrEDTA results showed that dietary FOS increased intestinal permeability in rats in accordance 
with our previous study[5]. The FOS induced increase in intestinal permeability reduces intestinal 
barrier function as reported earlier[5]. We focused on the colon since fermentation of FOS occurs in 
cecum and colon and is very limited in the ileum [18, 23]. Furthermore, by additional use of lactulose/ 
mannitol as permeability labels [24] we found that FOS increased intestinal permeability in the large 
intestine and not in the small intestine (unpublished results). Individual colonic gene expression of 12 
rats after ≈2 weeks FOS versus control feeding were explored on whole genome level and showed 
that the increased permeability could not be explained by changes in genes belonging to the tight 
junction system in the colon. No significant changes were observed in claudin 2 and 4, cadherins or 
tight junction protein 1. With our focus on gene expression, possible changes in protein levels and 
cellular localization or modification cannot be excluded. 19 Genes related to apoptosis were affected 
by FOS with only modest fold changes. Although some pro-apoptotic genes were mildly affected (eg 
Bax, Caspase 7), no changes were seen in many key pro-apoptotic genes such as Bad, Caspase 3 
and Apaf1. Therefore, we feel that apoptosis is not the main cause of the increased intestinal 
permeability observed. Known mucosal defense genes such as defensins, mucins and calprotectin 
were also unaffected by FOS. These few and small transcriptional changes in potential barrier related 
genes cannot explain the profound and consistent effects of FOS on intestinal permeability in rats. We 
can not fully exclude that dilution of specific cell types in the heterogeneous cell population of mucosal 
scrapings has lead to undetectable levels of some expected genes, e.g. mucin genes. This could be 
further assessed by laser microcapture dissection, which allows isolation of specific cell types from the 
intestine [25], and subsequent gene expression analysis by Q-PCR.  On the other hand, we identified 
multiple genes associated with energy metabolism (177 mitochondria related genes) that were 
significantly modified by FOS. Protein turnover was also clearly affected by FOS (113 genes). 
Coincidence of increased permeability and upregulation of these genes suggests that these processes 
play a major role in preservation of intestinal mucosal integrity. 
 
The most striking observation was the induction of a broad range of mitochondrial genes. Increased 
expression of mitochondrial genes is commonly observed during disturbed ATP homeostasis caused 
by increased energy demand or decreased mitochondrial energy supply[11-14]. Most of the genes 
reported to be changed by disturbed ATP homeostasis were also induced by FOS (Ant, 24 NADH 
dehydrogenases, 7 Cox subunits and 3 ATPases). This could be confirmed at protein level for complex 
IV subunit II. Together this strongly suggests that FOS caused ATP depletion in colonic epithelial cells.  
The increase in mitochondrial genes could indicate a compensation for possible SCFA -induced ATP 
depletion. The validity of this assumption could be studied by measuring ATP levels in enterocytes of 
FOS- and control-fed rats. The clear changes of FOS on mitochondrial processes were not expected 
beforehand, therefore no precautions were taken at the time of sampling and storage of the mucosal 
scrapings that would allow post-hoc analysis of ATP levels. Alternatively we attempted to examine 
levels of phosphorylated AMP-activated protein kinase (AMPK) as this reflects the ADP/ATP ratio in 
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cells [26]. Low levels of total AMPK protein could be detected in colonic scrapings without difference 
between control and FOS (data not shown). However, AMPK phosphorylation could not be detected in 
mucosal scrapings, most certainly because of instability of the phosphorylated protein requiring 
specific sample collection procedures. In addition it would be interesting to study the effects of FOS on 
mitochondria using electron microscopy studies [27].   
So, the question remains whether the strongly and broadly increased expression of mitochondrial 
genes by FOS, is associated with the observed increase in intestinal permeability in FOS-fed rats. 
Many studies using epithelial cell lines have shown that paracellular hyperpermeability is caused by 
ATP depletion[28-30]. Another strong indication that mitochondria are important in maintaining 
intestinal permeability is derived from studies on chronic NSAIDs [31]. Direct exposure of rat intestine 
to the NSAID indomethacin or the mitochondrial uncoupler DNP increases epithelial permeability [32-
34], which  increased bacterial translocation in rats and intestinal cell lines, and increased immune cell 
infiltration and ulceration in rats [32, 35]. Enhanced bacterial translocation reflects impaired barrier 
function.  
In figure 5, we schematically describe a possible mechanism of the FOS induced increase in intestinal 
mitochondrial gene expression, the proposed ATP-depletion and the increased mucosal permeability 
observed.  
Previous studies in rats[3, 36, 37] and humans[38] showed rapid fermentation of FOS in cecum and 
colon by the endogenous microflora resulting in lactic acid accumulation, SCFA production, and 
decreased pH of luminal contents. Although luminal production of modest quantities of SCFAs is 
essential for normal colonic mucosal function[39], overproduction or accumulation of SCFA along with 
low pH in the intestinal lumen has been shown to cause intestinal injury leading to increased intestinal 
permeability in vivo [40-42] and in vitro [43, 44]. Studies in liver show that SCFA induced depletion of 
cellular ATP coincided with a reduced intracellular pH (pHi) [45]. A likely explanation for reduced pHi by 
SCFA is that in an acidic luminal environment, a relatively larger portion of SCFA becomes protonated, 
facilitating passive diffusion of SCFA across the apical hydrophobic enterocyte membrane causing 
intracellular acidification [46, 47]. The above mentioned studies were done in vitro or in perfused liver, 
but the concentrations applied can impair the pHi homeostasis in colonocytes in FOS fed rats[36, 48]. 
Taken together, FOS reduce luminal pH and increase levels of SCFAs, likely leading to acidification of 
the cellular cytoplasm (decrease in pHi). A decrease in pHi is compensated by H+ excretion in 
exchange for Na+ by the pHi regulating Na+/HCO3- cotransporter (NBC) and the Na+/H+ exchanger 
(NHE) in the basolateral membrane [49, 50]. This indirectly activates the Na+,K+-ATPase (ATP1) 
which is known to require ~25% of the cellular ATP turnover under basal conditions[51]. Long-term 
exposure of enterocytes to high SCFA concentrations under low pH conditions might therefore disturb 
or exhaust plasma membrane pumps, leading to rapid ATP-depletion[43]. FOS diet significantly 
increased expression of Atp1b1 (1.2-fold, p<0.001). No changes were found in the gene expression of 
the transporters Nbc and Nhe, but increased activity of these transporters can occur without 
concomitant changes in mRNA gene expression.  
A strong indication supporting SCFA and low luminal pH as inducers of the observed effects, are 
results of previous studies of our lab showing that the adverse affects of FOS on mucosal barrier, i.e. 
            
 
 10 
increased permeability and decreased resistance to pathogens, are absent when calcium is 
supplemented to the diets[4]. Calcium is known to increase the buffering capacity of luminal contents 
by its precipitation with dietary phosphate. By preventing acidification during fermentation, SCFA will 
remain in the anionic form, for which the cellular plasma membrane is not permeable. Other possible 
mechanisms may play a role, including SCFA induced accumulation of Acyl CoA in mitochondria, 
opening of the pore complex or modulation of histone deacetylase activity by butyrate followed by an 
altered PGC1 expression, but none of these mechanisms were supported by consistent changes in 
gene expression.  
 
The second major process affected by FOS was protein turnover. FOS induced 27 ribosomal proteins 
and 30 proteasomal genes, indicating increased protein turnover. Intracellular proteins are targeted to 
the proteasomal degradation system by ubiquitination[52]. Proteasomal degradation is tightly 
controlled and removes denatured, misfolded and damaged proteins. The clear increase in 
proteasomal gene expression might result from increased presence of misfolded proteins. One 
common cause of misfolding of cellular proteins is mild oxidative stress[53]. FOS induced several 
genes related to oxidative stress, such as metallothionein-2 (Mt2) metallothionein-1a (Mt1a), six 
glutathione S-transferases (Gst’s), heme oxygenase 1 (Hmox1), and superoxide dismutase 1 and 3 
(Sod1 and Sod3). An increase in oxidative stress proteins is an indirect marker for production of 
reactive oxygen species (ROS)[54]. It is well recognized that induced mitochondrial activity can 
increase production of ROS. The increased expression of oxidative stress genes and mitochondrial 
genes observed in the present study suggests increased mitochondrial activity, possibly associated 
with increased ROS production and increased protein oxidation. Oxidized proteins are often misfolded, 
and directed to proteasomes for degradation. In support, the translocase Sec61 responsible for 
intracellular transport of misfolded proteins from the ER to the proteasome was significantly increased 
1.4 fold (p<0.001) by FOS. 
Increased proteasomal gene expression might also reflect the formation of immunoproteasomes (I-
proteasomes) [55]. The I-proteasome plays a role in antigen processing and is composed of two 
subunits PSME1 and PSME2 [55] which were both significantly increased by FOS supplementation. 
Expression of these subunits is known to be induced by microbial infection and cytokines like IFNγ 
[56].  Alterations in the I-proteasome in the injured intestinal epithelium are observed in colon biopsies 
of IBD patients and IBD-mouse models[55, 57]. The increased intestinal permeability due to the FOS 
diet can cause increased exposure of the mucosa to bacteria and therefore induce I-proteasome gene 
expression. 
 
The top 10 most significantly changed genes by FOS showed to be good representatives of the major 
biological processes selected from pathway analysis. In addition to genes related to mitochondria and 
protein turnover, two genes coding for cellular retinol-binding proteins (Rbp7 and Rbp2) were highly 
induced by FOS. RBPs are required for uptake, intracellular transport and metabolism of vitamin A. 
Vitamin A is a fat-soluble vitamin necessary for growth and differentiation of epithelial tissues. RBP7 
and RBP2 belong to the fatty-acid binding protein (FABP) family. FOS also significantly increased 
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Fabp1 2.9 fold. At present, we cannot explain the FOS induced expression of these genes and its 
relation to the functional effects observed in this and our earlier FOS studies. 
Proglucagon is one of the most highly induced gene by FOS (2.6-fold, p<0.001). The proglucagon 
gene is a precursor encoding several glucagon-like peptides. In intestinal enteroendocrine cells the 
gene codes for oxyntomodulin, GLP1 and GLP2[58]. This gene was previously found to be induced by 
non-digestible oligosaccharides[59]. Besides FOS induced expression of proglucagon, FOS induced 
the expression of several other gut-derived peptide hormones, namely cholecystokinin (Cck), peptide 
YY (Pyy) and pancreatic polypeptide (Ppy). Increase of PYY has previously been reported in rat colon 
by SCFA[60]. Proglucagon, PYY, PPY and CCK are all expressed by enteroendocrine L cells in colon 
and play a role in gut-nutrient sensing[61]. In the hypothalamus nutrient sensing is also regulated by 
these hormones and directly related to ATP status[62]. It is speculated that the same mechanism is 
applicable to enteroendocrine L cells in de gut[60]. Since in our study, increased gene expression of 
these 4 peptide hormone genes coincides with alterations in mitochondrial processes, it is tempting to 
speculate that these hormones also influence or respond to energy metabolism in intestinal epithelial 
cells. Besides a role in energy homeostasis, GLP-2, PYY and CCK have growth-promoting properties 
on the intestinal epithelium in vivo[63]. GLP1 stimulated cell proliferation has been reported for liver 
and pancreas[64]. GLP2 is involved in regulation of mucosal epithelial integrity[65]. It stimulates 
intestinal crypt cell proliferation[66] and reduces apoptosis, therefore enhances mucosal regeneration. 
It has beneficial effects on many causes of intestinal injury, such as stress, vascular ischemia, NSAID 
administration and chemically induced injury in rodents, and decreases subsequent intestinal 
permeability[67, 68]. The upregulation of these genes might thus be a response to the impaired 
intestinal barrier in FOS-fed rats. 
 
FOS consistently increased intestinal permeability, but the present study showed hardly any effect on 
expression of well known intestinal integrity genes in the colon. Most surprisingly no changes were 
observed in genes related to tight junctions that were expected since tight junctions are key regulators 
of paracellular transport. However, changes in epithelial permeability are a result of internalization of 
the tight-junction proteins occludin, claudin and junctional adhesion molecule-A[69]. These cellular 
translocations can occur without concomitant changes in mRNA gene expression. Detection of such 
effects would require a different approach from transcriptomics. Immunohistochemistry could show 
whether translocation of TJ proteins occurred in the FOS fed rats compared with control fed rats and is 
under current investigation.  
 
Conclusion 
 
Altogether we show that altered barrier integrity induced by dietary FOS in rats coincides with a clear 
increase in colonic mitochondrial gene expression, suggesting that mitochondrial energy metabolism is 
important for maintaining the intestinal barrier. The role of mitochondria in maintenance of the 
intestinal barrier is accepted in NSAID and DNP uncoupling studies. We speculate that FOS induced 
excess production of SCFA and acidification of luminal contents might result in SCFA induced ATP 
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depletion of colonic epithelial cells. Insight into the role of mitochondrial function and ATP depletion is 
of relevance, not only for the application of FOS and other prebiotics in food products on the current 
market, but especially for mechanistic understanding of intestinal disorders where gut permeability 
changes are observed.  
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Methods 
 
Animals and diet  
The animal welfare committee of Wageningen University (Wageningen, the Netherlands) approved the 
experimental protocol. Specific pathogen-free male outbred Wister rats (8 weeks old, mean body 
weight of 253 g; n=36 in total), were housed individually in metabolic cages. All animals were kept in a 
temperature (22-24°C) and humidity (50-60%) controlled room with a 12 h light/dark cycle (lights on 
from 6 AM to 6 PM). Rats (two dietary groups, n=18 each) were fed restricted quantities (14 g/day) of a 
purified diet during the entire experimental period. Restricted food intake was necessary to prevent 
differences in food consumption and hence differences in vitamin and mineral intake as observed 
earlier in FOS interventions[3]. The diet contained (per kg) 200 g acid casein, 502 g glucose, 160 g 
palm oil, 40 g corn oil, 20 g cellulose, 35 g mineral mix (without calcium) and 10 g vitamin mix 
according to AIN93 recommendations[70]. Diets contained 20 g/kg cellulose at least and were 
supplemented with either 60 g/kg FOS (purity 93%; Raftilose P95, Orafti, Tienen, Belgium) or 
additional 60 g/kg cellulose as described earlier[3]. Diets were low in calcium (20 mmol 
CaHPO4.2H2O/kg) and high in fat content (200 g fat/kg) to mimic the composition of a Western human 
diet. Demineralized drinking water was supplied ad libitum.  
To follow intestinal permeability, 6 of the 18 rats of each dietary group received their diet supplemented 
with the intestinal permeability marker chromium ethylenediamine-tetraacetic acid (CrEDTA). The 
CrEDTA solution added to the diet was prepared as described elsewhere[5]. After feeding the diets for 
16 days, rats were killed by carbon dioxide inhalation. Rats fed diets containing the permeability 
marker CrEDTA (n=6 per diet group) were not included in the gene expression study, to exclude 
possible interaction of CrEDTA on colonic gene expression. From the remaining 12 rats per dietary 
group, the colon was taken out, longitudinally opened and colonic contents were removed by a quick 
rinse in 154 mM KCl. Colonic mucosa was scraped off using a spatula. Scrapings were immediately 
frozen in liquid nitrogen and stored at -80°C. The scrapings were homogenized in liquid N2 using a 
mortar and pestle cooled with liquid N2 (Fisher Emergo, Landsmeer, The Netherlands). One third of the 
pulverized samples was used for protein determination and the remaining part for RNA isolation. 
 
Analysis of urine samples 
Total 24 h urine samples were collected on days 14 and 15 from rats fed the control and FOS diet (n=6 
each) supplemented with CrEDTA. Urines were preserved by adding oxytetracycline (1 mg) to the 
urine collection vessels of the metabolic cages, and analyzed for the intestinal permeability marker 
CrEDTA  as described elsewhere[5]. CrEDTA data were analyzed using the Student’s t-test (two-sided) 
using Prism 4 (GraphPad software Inc., San Diego, CA). 
 
RNA isolation 
Total RNA was isolated from colon scraping homogenates using TRIzol reagent (Invitrogen, San 
Diego, CA) according to the manufacturer’s instructions. Total RNA was purified using Rneasy 
columns (Qiagen, Chatsworth, CA). Absence of RNA degradation was checked on a 1% TBE/agarose 
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gel after 1 hour incubation at 37°C. RNA purity and concentration were measured with the Nanodrop 
(Isogen Life Science, Maarssen, The Netherlands). OD A260/A280 ratios were all between 2.08 and 2.10 
indicating RNA of high purity. 
 
Analysis of mRNA expression by Oligo Arrays 
For microarray hybridization, RNA of each individual animal was labeled with Cy-5. A standard 
reference sample, consisting of a pool of all colonic RNA was labeled with Cy-3. For each oligo array, 
35 µg of total RNA was used to make Cy-5 or Cy-3 labeled cDNA. Total RNA was mixed with 4 µg T21 
primer, heated at 65°C for 3 min (RNA denaturation) followed by 25°C for 10 min (primer annealing). 
cDNA was synthesized by adding 5x first strand buffer (Invitrogen), 10 mM DTT, 0.5mM dATP, 0.5 mM 
dGTP, 0.5 mM dTTP, 0.04 mM dCTP, 0.04 mM Cy5-dCTP or Cy3-dCTP, 1.2U RnaseOUT and 6U 
SuperScript II Reverse Transcriptase to a total volume of 62.5 µL. The reaction was incubated at 42°C 
for 2 h. Purification, precipitation and denaturation of the labeled cDNA were performed as previously 
described[71]. 
Each labeled cDNA sample was individually hybridized on the 44K rat whole genome Agilent array 
(G4131A, Agilent Technologies, Inc. Santa Clara, CA)  consisting of 44290 60-mer rat oligonucleotide 
probes, including ~3000 control spots. The Cy5 labeled cDNAs of the individual rats were mixed 1:1 
with the Cy3 labeled reference cDNA, mixed with 2x hybridization buffer (Agilent Technologies) and 
10x control targets (Agilent Technologies) and hybridized for 17 hours at 60°C in Agilent hybridization 
chambers in an Agilent hybridization oven rotating at 4 rpm (Agilent Technologies). After hybridization 
the arrays were washed with an SSPE wash procedure (Agilent Technologies) and scanned with a 
Scanarray Express HT scanner (Perkin Elmer). 
 
Data analyses and functional interpretation of microarray data  
Spot intensities were quantified using ArrayVision 8.0 (GE Healthcare life sciences). Median density 
values and background values of each spot were extracted for both the experimental samples (Cy5) 
and the reference samples (Cy3). Subsequently, quality control was performed for each microarray 
using both LimmaGUI package in R from Bioconductor and Microsoft Excel. One array in the dietary 
FOS group did not pass the quality control based on MA plot and signal intensity distribution [72]. 
Therefore, the dataset contained 23 arrays in total. Data was exported into GeneMaths XT (Applied 
Maths, Sint-Martens-Latem, Belgium) for background correction and normalization. We discarded 
spots with an average intensity, over all arrays, of Cy5 lower than 1.5-fold above average background. 
Then, the Cy5 intensities were normalized against the Cy3 reference as described previously[73]. The 
data have been deposited in NCBIs Gene Expression Omnibus[74] and are accessible through GEO 
Series accession number GSE5943. The complete dataset is available in additional files 4 and 5. Fold 
changes calculations were performed in Microsoft Excel, fold change equals ratio FOS/control in the 
case of increase or equals -1/ratio in the case of decrease. For statistical identification of differentially 
regulated probes between the control and FOS group we used two complementary tests, the often 
used t-test and Random Forest (RF). T-test was performed in GeneMaths XT, the generated p-values 
were used to obtain insight into significantly affected genes. To correct for multiple testing we used 
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FDR-adjusted p-values (GeneMaths XT), so called q-values[75]. For t-test we choose a stringent 
threshold of p<0.001. The corresponding q-value was 0.035, meaning that 3.5% of the genes selected 
by this p-value could be false positive. The t-test tests each gene independently and therefore will 
miss genes that have no main effect but are related to the treatment in gene-gene interaction[76]. We 
therefore used RF, available as R-package[77, 78], as a complementary method as that method 
includes genes that in gene-gene interaction are related to treatment besides including genes with a 
main treatment effect. RF was recently successfully used in several microarray studies[19, 20]. The 
method provides an importance index for each gene. This value is dependent on the main treatment 
effect of a gene. In addition, gene-gene interaction related to the treatment increases importance index 
value of genes[20]. For RF we defined a threshold where the importance index of each gene in the 
real dataset exceeded the importance index of genes obtained from analysis of 100 randomly 
permuted datasets, using randomly assigned class labels FOS or control. This indicates that these 
genes are truly related to the treatment[79] (detailed method described in[80]). We included the genes 
that were selected by the t-test threshold and the genes selected by the RF threshold. These genes 
were considered significantly changed by FOS. 
To interpret functional changes in the dataset, we applied two pathway analysis programs, Metacore 
and GSEA, with different complementary pathway-classification properties. Pathway analysis of the 
selected genes was performed using MetaCore (GeneGo Inc, St. Joseph, MI). We used classification 
based on GO-term and classification based on GeneGo annotation. The GeneGo annotation database 
is a curated database of gene networks based on several databases (KEGG, GO) and scientific 
literature[21]. We also performed a pathway analysis with GSEA (Broad Institute), a method that does 
not require preselection of genes by a statistical threshold but uses the whole dataset. GSEA is 
thoroughly described by Subramanian et al[81]. This method prevents possible selection bias[82, 83]. 
We used the c2 functional genesets based on publicly available and curated databases (GenMapp, 
Biocarta and SigmaAldrich). Only processes with 5-500 genes were taken into account. Agilent gene 
annotation version 20060331 was used for both programs. We selected pathways with p<0.001 in 
metacore and q-value<0.25 in GSEA, in accordance with the recommendation of the GSEA 
developers[81]. 
Since only about 30% of the genes on the whole genome array were recognized in both pathway 
programs, we manually supplemented the significantly enriched biological processes with non-
annotated genes from the selected gene-set using biological databases (Biocarta, SOURCE, 
GenMAPP, KEGG) and scientific literature. As processes overlap, we bundled some processes and 
renamed them. 
 
Analysis of mRNA expression by Real-time Quantitative RT-PCR 
Real-time Quantitative RT-PCR (Q-PCR) was performed on individual samples (n=12 per group). 1 µg 
of RNA of all individual samples was used for cDNA synthesis using the iScript cDNA synthesis kit of 
Bio-Rad Laboratories (Veenendaal, The Netherlands). Real-time reactions were performed by means 
of the iQ SYBR Green Supermix of Bio-Rad using the MyIQ single-color real-time PCR detection 
system (Bio-Rad). Each reaction (25 µl) contained 12.5 µl iQ SYBR green supermix, 1 µl forward 
            
 
 16 
primer (10 µM), 1 µl reverse primer (10 µM), 8.5 µl RNase-free water and 2 µl diluted cDNA. The 
following cycles were performed: 1x 3 min at 95°C,  40 amplification cycles (40x 10 s 95°C, 45 s 
60°C), 1x 1 min 95° C, 1x 1 min 62°C and a melting curve (80x 10 s 55°C with an increase of 0.5°C 
per 10 s). A negative control without cDNA template was run with every assay. The optimal melting 
point of dsDNA (Tm) and the efficiency of the reaction were optimized beforehand. Data were 
normalized against the reference genes Pleckstrin homology domain containing, family A member 6 
(Plekha6), Nucleoporin 37 (Nup37) and β-actin. Plekha6 and Nup37 were chosen because our 
microarray data showed equal expression levels for all microarrays, and β-actin was chosen because 
it is a well accepted reference gene. Primers were designed using Beacon designer 7.00 (Premier 
Biosoft International, Palo Alto, CA). For primer sequences see additional file 6. A standard curve for 
all genes, including reference genes, was generated using serial dilutions of a pooled sample (cDNA 
from all reactions). mRNA levels were determined using delta CT method (IQ5 software version 2.0, 
Bio-Rad version). Analysis of all individual samples was performed in duplicate. Data were analyzed 
using Student’s t-test (two-sided) using Prism 4. Differences were considered statistically significant 
when p<0.05. 
 
Protein determination 
Mucosal scrapings of individual rats or pools of all rats per group (n=12) were lysed in a buffer 
containing 0.125 M TrisHCl pH 6.8, 2% SDS and 20% glycerol. Protein concentrations were 
determined using DC protein assay kit (Bio-rad Laboratories, Veenendaal, the Netherlands). All 
samples were boiled in sample buffer (0.125 M TrisHCl pH 6.8; 2% SDS; 20% glycerol; 2% β-
mercaptoethanol; 0.04% coomassie briljant blue), and separated by 14% SDS-PAGE. The proteins 
were transferred onto a nitrocellulose membrane. Immunoblot analysis was performed with a 1:2000 
dilution monoclonal antibodies against OXPHOS complexes, Complex IV subunit II (COXII) 
monoclonal antibody (MS601, Mitosciences, Eugene, OR, USA) or with a 1:200 dilution of monoclonal 
anti-GLP1 antibody (Abcam (Ab23468), Cambridge, UK) by incubation in 2.5% protifar/TBS-T for 1½ 
hr at RT.  After incubation, blots were washed in TBS-T and incubated  1 hr at RT with a 1:2000 dilution 
horseradish peroxidase-conjugated anti-mouse IgG (7076, Cell Signaling, Danvers, MA, USA) for 
detection GLP1 or a 1:2500 dilution of horseradish peroxidase-conjugated anti-mouse IgG (W4021, 
Promega, Madison, WI, USA) for detection of Complex IV. The signal was detected using an enhanced 
chemiluminescence detection system (GE Healthcare, The Netherlands) according to the protocol of 
the supplier. After washing the membranes thoroughly with TBS-T, they were subsequently incubated 
with the monoclonal anti-Actin (1:100 dilution, Santa Cruz, sc-1615) and HRP anti-goat (1:10000 
dilution, Promega. V8051). The intensities of GLP-1, COXII and actin signals on the autoradiography 
films were quantified using geldoc (Bio-Rad). GLP-1 and COXII quantities were normalized to actin to 
correct for loading differences. 
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Figure legends 
 
Figure 1. Average urinary CrEDTA excretion in the control and FOS group. Daily dietary CrEDTA 
intake was 54µmol. Urines were collected at days 14 and 15. Results are expressed as mean ± SEM 
(n=6 per diet group). The FOS group significantly differed from the control group (***p<0.001). 
 
Figure 2. Classification of the genes affected by FOS into biological processes. Analyzed by 
Metacore, GSEA and data mining 
 
Figure 3. Mucosal scrapings (pool of n=12 per group) were examined for complex IV subunit COXII 
protein levels. The experiment was performed three times with independent, pools, showing a 1.5; 1.7 
and 2.7 fold difference in COXII protein expression relative to Actin, respectively. The 1.5 fold increase 
is shown. 
 
Figure 4. Relative expression of Proglucagon mRNA (gray bar) and GLP-1 protein (black bar) in 
colonic mucosa of a random selection of control fed and FOS fed rats. mRNA and protein levels were 
normalized to Actin levels. Expression is shown as means ± SEM (n=7). **p<0.01, ***P<0.001 
 
Figure 5. Proposed mechanism of dietary FOS induced intestinal permeability 
1 High levels of FOS fermentation products increase intestinal permeability in vivo [5, 40, 41]. 
2 Excess SCFAs cause intracellular acidification of epithelial cells. When protonated-SCFA diffuse 
from the gut lumen into epithelial cells [47, 84]. The SCFA cause intracellular acidification and induce 
proton pump activity (NHE and NBC transporters) which may lead to ATP depletion [43, 45] 
3 Reduced ATP levels, by increased energy demand, chronic mitochondrial uncoupling or any other 
cause of disturbed energy metabolism, are compensated by increased mitochondrial gene expression 
and mitochondrial biogenesis [27, 85].   
4 Disturbed energy metabolism leads to increased permeability. In agreement: ATP-depletion in 
epithelial cell lines causes paracellular hyperpermeability [28-30] and uncoupling of intestinal 
mitochondria leads to increased bacterial translocation, immune cell infiltration and ulceration in rats 
[31, 32].  
Calcium supplementation of a FOS diet counteracts FOS induced intestinal permeability. Calcium 
prevents acidification of intestinal contents during fermentation and thus formation of protonated-
SCFA. 
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Tables 
 
Table 1. Top 10 of highest ranked genes by t-test and Random Forest.  
Gene name Sequence ID Gene 
Symbol 
Fold 
change* 
p value 
Glucagon gene, exon 6  K02813 Glc 2.6 5E-10 
Cellular retinol-binding protein 7 P02696 Crbp 4.0 2E-09 
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 XM_215544 Ndufb5 1.3 3E-08 
Unknown (LOC295337)  XM_215660 - 1.6 4E-08 
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 XM_216378 Ndufb6 1.5 7E-08 
ATP synthase, H+ transporting, mitochondrial  F0 complex, subunit b, 
isoform 1  
NM_134365 Atp5f1 1.4 3E-07 
Protein C11orf10, LOC309206 XM_219574 - 1.4 3E-07 
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4 NM_010886       Ndufa4 1.4 3E-06 
Metallothionein-2  BF556648 Mt2 1.9 4E-06 
Proteasome subunit alpha type 3-like  BN000326 Psma3l 1.4 7E-06 
*Fold change FOS/ control 
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Table 2. Detailed classification of biological processes affected by FOS. 
Biological process 
                                           Number of genes  
                                           affected by FOS* 
Mitochondria Complex I 27 
 Complex II 5 
 Complex III 2 
 Complex IV 13 
 Complex V 21 
 Metabolism and TCA cycle 53 
 Mitochondrial ribosomes 33 
 Protein transport 11 
 Miscellaneous 12 
Protein turnover Protein degradation  31 
 Translation 44 
 Protein maturation 32 
 Miscellaneous 6 
Transcription Chromatin related 22 
 mRNA metabolism 7 
 Transcription 26 
 Miscellaneous 6 
Cell turnover Apoptosis 19 
 Growth/ Differentiation 16 
Mucosal barrier  30 
Cytoskeleton  26 
Transport  20 
Oxidative stress  16 
Vesicle related  10 
Peptide hormones  6 
Other†  503 
  997 
* Genes with p-value<0.001 or selected by RF threshold 
† Genes with less than 5 other genes belonging to the same process, unknown genes and, genes not part of a known process.   
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Table 3 Q-PCR confirmation of microarray data.  
  
Micro-
array  
Q-PCR 
Gene name 
Gene 
symbol sequence ID Ratio*    Ratio* SEM± p-value† 
Mitochondria        
Complex I        
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9  Nduf9b XM_216929 1.47  1.29 0.05 0.001 
Complex II        
Succinate dehydrogenase complex, subunit B, iron sulfur (Ip) Sdhb XM_216558 1.43  1.32 0.05 <0.001 
Complex III        
Ubiquinol-cytochrome c reductase binding protein Uqcrb XM_001074024 1.53  1.28 0.05 0.005 
Complex IV        
Cytochrome c oxidase subunit VIIb Cox7b NM_182819 1.61  1.36 0.06 0.001 
Complex V        
ATP synthase, H+ transporting, mitochondrial F0 complex, 
subunit G ATP5g XM_001075306 1.52  1.15 0.05 0.11 
Metabolism and TCA cycle        
Aldo-keto reductase family 1, member B8 Akr1b8 NM_173136 2.13  2.15 0.22 0.006 
Malic enzyme 1 Me1  1.65  1.76 0.11 <0.001 
Mitochondrial ribosomes        
Mitochondrial ribosomal protein S16 Mrps16 XM_001064095 1.43  1.20 0.05 0.03 
Mitochondrial protein transport        
Translocase of inner mitochondrial membrane 8 homolog b  Timm8b NM_022541 1.45  1.19 0.06 0.09 
Protein turnover        
Proteasome subunit alpha type 3-like Psma31 BN000326 1.39  1.24 0.04 0.002 
Mucosal barrier        
Phospholipase A2, group IIA (platelets, synovial fluid) Pla2g2a NM_031598 3.73  4.70 0.87 0.03 
Trefoil factor 3 Tff3 NM_013042 1.7  1.21 0.05 0.04 
Top 10 gene        
Retinol binding protein 7 Rbp7 XM_575960 2.06  3.72 0.36 <0.001 
Peptide hormone        
Proglucagon Gcg NM_012707 2.56  2.91 0.23 <0.001 
* Ratio FOS diet/ Control diet. 
± SEM of Q-PCR data is given (n= 12 per group) 
† p-value of Q-PCR data is given, the p-value of microarray data were all <0.001. 
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Additional files 
 
Additional file 1 
File format: doc 
Title: Barrier associated genes 
Description: The effect of FOS on the expression of potential barrier associated genes. 
 
Additional file 2 
File format: doc 
Title: Functional classification of FOS affected genes by Metacore  
Description: Classification of the genes affected by FOS into biological processes analyzed by 
Metacore. 
 
Additional file 3 
File format: doc 
Title: Genesets enriched in FOS versus control dataset according to GSEA analysis  
Description: Classification of the genes affected by FOS into biological processes analyzed by GSEA. 
 
Additional file 4 
File format: doc 
Title: FOS affected genes: Biological processes 
Description: Genes affected by FOS and part of a significant biological process.  
 
Additional file 5 
File format: doc 
Title: FOS affected genes: Miscellaneous 
Description: Genes affected by FOS but not part of a significantly regulated biological process or 
genes with unknown function. 
 
Additional file 6 
File format: doc 
Title: Primer sequences 
Description: Sequences of the primers used for Q-PCR analysis. 
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